|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.29 USD | -2.25% |
|
-5.44% | -16.30% |
| Capitalization | 9.39B 8.09B 7.59B 7.06B 13.01B 847B 14.19B 88.46B 34.25B 400B 35.26B 34.5B 1,465B | P/E ratio 2026 * |
47x | P/E ratio 2027 * | 40.7x |
|---|---|---|---|---|---|
| Enterprise value | 9.34B 8.04B 7.55B 7.01B 12.93B 842B 14.1B 87.92B 34.05B 397B 35.04B 34.29B 1,456B | EV / Sales 2026 * |
7.63x | EV / Sales 2027 * | 6.88x |
| Free-Float |
99.46% | Yield 2026 * |
0.53% | Yield 2027 * | 0.53% |
Last Transcript: Bio-Techne Corporation
| 1 day | -2.25% | ||
| 1 week | -5.44% | ||
| Current month | -6.54% | ||
| 1 month | +5.02% | ||
| 3 months | +11.42% | ||
| 6 months | +23.82% | ||
| Current year | -16.30% |
| 1 week | 59.95 | 64.72 | |
| 1 month | 56.97 | 66.06 | |
| Current year | 46.01 | 79.28 | |
| 1 year | 46.01 | 79.28 | |
| 3 years | 46.01 | 89.91 | |
| 5 years | 46.01 | 135.96 | |
| 10 years | 19.99 | 135.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 58 | 31/01/2024 |
James Hippel
DFI | Director of Finance/CFO | 54 | 31/03/2014 |
David Clair
IRC | Investor Relations Contact | - | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 01/11/2012 | |
John Higgins
BRD | Director/Board Member | 55 | 18/05/2009 |
Alpna Seth
BRD | Director/Board Member | 62 | 25/10/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.25% | -5.44% | -19.08% | -26.43% | 9.39B | ||
| +0.99% | -1.19% | +5.06% | +20.04% | 47.68B | ||
| -1.01% | -2.14% | +10.33% | +6.25% | 38.07B | ||
| +1.11% | -2.71% | +58.78% | +62.61% | 36.13B | ||
| +2.07% | +0.70% | +13.44% | +20.39% | 27.89B | ||
| +0.19% | -6.60% | +56.67% | +161.68% | 15.47B | ||
| +0.53% | +5.62% | +66.55% | +223.47% | 15.48B | ||
| -2.03% | +1.33% | -16.26% | -8.26% | 13.91B | ||
| +0.50% | +4.01% | +52.74% | - | 13.71B | ||
| -0.21% | -0.59% | +113.88% | +114.50% | 13.2B | ||
| Average | -0.01% | -0.61% | +34.21% | +63.81% | 23.09B | |
| Weighted average by Cap. | +0.31% | -0.84% | +29.71% | +51.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.22B 1.05B 989M 920M 1.7B 110B 1.85B 11.53B 4.46B 52.12B 4.6B 4.5B 191B | 1.31B 1.13B 1.06B 983M 1.81B 118B 1.98B 12.32B 4.77B 55.71B 4.91B 4.81B 204B |
| Net income | 202M 173M 163M 151M 279M 18.17B 304M 1.9B 735M 8.58B 756M 740M 31.43B | 235M 203M 190M 177M 326M 21.22B 355M 2.22B 858M 10.02B 883M 864M 36.7B |
| Net Debt | -57.07M -49.13M -46.12M -42.87M -79.02M -5.14B -86.21M -537M -208M -2.43B -214M -210M -8.9B | -390M -335M -315M -293M -540M -35.13B -589M -3.67B -1.42B -16.59B -1.46B -1.43B -60.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/12/25 | 60.29 $ | -2.25% | 2,070,615 |
| 05/12/25 | 61.68 $ | -2.93% | 1,764,985 |
| 04/12/25 | 63.54 $ | -0.44% | 1,442,714 |
| 03/12/25 | 63.82 $ | +1.38% | 1,783,107 |
| 02/12/25 | 62.95 $ | -1.27% | 1,368,627 |
Delayed Quote Nasdaq, December 08, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TECH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















